Lithium, an inhibitor of GSK-3β, has been widely used to treat mood disorders (Vazquez et al. 2021), implicating the role of GSK-3β in mood disorders (Costemale-Lacoste et al. 2016). The gene discussed is GSK3B; the disease is mood disorder.